Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - Expert Opinion on …, 2019 - Taylor & Francis
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …
被引用次数：51 相关文章

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION …, 2019 - iris.unicampania.it
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION ON …, 2019 - iris.unisa.it
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo… - Expert opinion on …, 2019 - pubmed.ncbi.nlm.nih.gov
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION ON …, 2019 - iris.unina.it
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …
[PDF] academia.edu

[PDF][PDF] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION ON …, 2019 - academia.edu
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …
[PDF] core.ac.uk

[PDF][PDF] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION ON …, 2019 - core.ac.uk
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study.

M Megna, L Di Costanzo, G Argenziano… - Expert Opinion on …, 2019 - europepmc.org
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …
[PDF] openaccessrepository.it

[PDF][PDF] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo… - EXPERT OPINION …, 2019 - openaccessrepository.it
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …
[PDF] archive.org

[PDF][PDF] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

M Megna, L Di Costanzo, G Argenziano… - EXPERT OPINION …, 2019 - scholar.archive.org
Background: Long term data on the real-life use of secukinumab are scant. The aim of this
study was to investigate the real-life effectiveness, safety and treatment persistence of …